Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotoxins: From Design to Clinical Application. | Biomolecules | 2021 | 34827694 | PubTator, text mining | PubMed |
| Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation. | Biomolecules | 2021 | 34827669 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1): A Novel Predictor for Recurrence of Hepatocellular Carcinoma After Curative Resection. | Med Sci Monit | 2021 | 34815375 | PubTator, text mining | PubMed |
| Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer. | Front Cell Dev Biol | 2021 | 34805157 | PubTator, text mining | PubMed |
| Involvement of immune system and Epithelial-Mesenchymal-Transition in increased invasiveness of clustered circulatory tumor cells in breast cancer. | BMC Med Genomics | 2021 | 34801010 | PubTator, text mining | PubMed |
| Circular RNA: A promising new star for the diagnosis and treatment of colorectal cancer. | Cancer Med | 2021 | 34796685 | PubTator, text mining | PubMed |
| Modulation of Microenvironment Signals by Proteolytic Shedding of Cell Surface Extracellular Matrix Receptors. | Front Cell Dev Biol | 2021 | 34796172 | PubTator, text mining | PubMed |
| CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease. | Neurol Genet | 2021 | 34786477 | PubTator, text mining | PubMed |
| MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness. | Cell Death Dis | 2021 | 34772924 | PubTator, text mining | PubMed |
| The BRD9/7 Inhibitor TP-472 Blocks Melanoma Tumor Growth by Suppressing ECM-Mediated Oncogenic Signaling and Inducing Apoptosis. | Cancers (Basel) | 2021 | 34771678 | PubTator, text mining | PubMed |
| Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors. | Cancers (Basel) | 2021 | 34771611 | PubTator, text mining | PubMed |
| Novel Treatment Strategies Utilizing Immune Reactions against Chronic Myelogenous Leukemia Stem Cells. | Cancers (Basel) | 2021 | 34771599 | PubTator, text mining | PubMed |
| Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure? | Int J Mol Sci | 2021 | 34769090 | PubTator, text mining | PubMed |
| Perfluorooctane sulfonate (PFOS) exposure of bovine oocytes affects early embryonic development at human-relevant levels in an in vitro model. | Toxicology | 2021 | 34762985 | PubTator, text mining | PubMed |
| Advancement of Scaffold-Based 3D Cellular Models in Cancer Tissue Engineering: An Update. | Front Oncol | 2021 | 34760696 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| Data-Driven Modeling of Breast Cancer Tumors Using Boolean Networks. | Front Big Data | 2021 | 34746770 | PubTator, text mining | PubMed |
| A Dynamic Transcriptome Map of Different Tissue Microenvironment Cells Identified During Gastric Cancer Development Using Single-Cell RNA Sequencing. | Front Immunol | 2021 | 34745098 | PubTator, text mining | PubMed |
| Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy? | Front Cell Dev Biol | 2021 | 34733848 | PubTator, text mining | PubMed |
| Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. | Nature | 2021 | 34732895 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=42